LONDON BROKER RATINGS: Jefferies rates Future at 'hold'; Spirent upped
15th Mar 2023 09:36
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More
(Alliance News) - AstraZeneca PLC on Thursday hailed phase 3 trial results on its lung cancer drugs Imfinzi and Tagrisso. Read More
(Alliance News) - AstraZeneca PLC on Monday hailed phase 2 trial results of its cancer drug Enhertu, which it develops with Daiichi Sankyo Co Ltd. Read More
(Alliance News) - Stocks in London were called to open flat on Monday, as the dollar softened ahead of a consequential week for US economic data and monetary policy guidance. Read More
(Alliance News) - AstraZeneca PLC and Merck & Co Inc said on Thursday that the US Food & Drug Administration will convene a meeting of the Oncologic Drugs Advisory Committee to discuss the supplemental new drug application for Lynparza in combination with abiraterone and prednisone or prednisolone. Read More
AstraZeneca PLC - Cambridge, UK-based pharmaceuticals firm - Announces wholly owned subsidiary AstraZeneca Finance prices a three tranche global bond offering totalling USD2.25 billion on February 28. Expects offering to close on March 3. Says the notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by AstraZeneca are USD1.1 billion of fixed rate notes with a coupon of 4.875%, maturing March 3 2028, USD650 million of fixed rate notes with a coupon of 4.900%, maturing March 3 2030, and USD500 million of fixed rate notes with a coupon of 4.875%, maturing March 3, 2033. Expects to use the net proceeds of the offering for general corporate purposes, which may include the refinancing of existing indebtedness. Read More
(Alliance News) - AstraZeneca PLC on Friday reported that it completed the acquisition of CinCor Pharma Inc, which focuses on hypertension and chronic kidney disease, while its cancer drug Enhertu won another approval, its first in China. Read More
(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend. Read More
(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings. Read More
(Alliance News) - AstraZeneca PLC on Thursday said it has signed an exclusive licence agreement alongside KYM Biosciences Inc for CMG901, an antibody drug conjugate looking to address gastric cancer. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its Imfinzi and Imjudo were approved in the European Union for the treatment of advanced liver and lung cancers. Its Calquence was also approved to treat chronic lymphocytic leukaemia. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More
(Alliance News) - AstraZeneca PLC on Tuesday said Beyfortus continues to show consistent protection against respiratory syncytial virus in infants. Read More
(Alliance News) - The Covid drug Evusheld will not be recommended by the NHS for people with weakened immune systems. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More
(Alliance News) - Stock prices in London closed lower on Friday, as news that the UK managed to avert a recession failed to inspire equities, with interest rate worries hanging over markets again. Read More
(Alliance News) - Chancellor Jeremy Hunt said he was disappointed the UK "lost out this time" on a GBP320 million new AstraZeneca PLC factory after the pharmaceutical company chose the low-tax Republic of Ireland instead. Read More
(Alliance News) - UK Chancellor Jeremy Hunt said he was disappointed the UK "lost out this time" on a GBP320 million new AstraZeneca PLC factory after the pharmaceutical company chose the low-tax Republic of Ireland instead. Read More
(Alliance News) - London's FTSE 100 hit another record high on Thursday as largely soothing words from the Bank of England governor lifted the mood, while equities in New York joined in on the action, with Walt Disney a star performer. Read More